Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Journal of Medical Economics|March 9, 2026
Economic and clinical value of hydrolyzed collagen in the management of spine surgery wounds: a cost-effectiveness analysisVivek Mohan, Joshua E Meyers, Benjamin G Cohen, et al.Acta Orthopaedica|November 19, 2013
Monoblock all-polyethylene tibial components have a lower risk of early revision than metal-backed modular componentsVivek Mohan, Maria C S Inacio, Robert S Namba, et al.The Journal of Arthroplasty|September 30, 2010
Unilateral vs bilateral total knee arthroplasty risk factors increasing morbidityDavid W Fabi, Vivek Mohan, Wayne M Goldstein, et al.The Journal of Arthroplasty|June 7, 2008
Influence of stem size on clinical outcome of primary total hip arthroplasty with cementless extensively porous-coated femoral componentsC Anderson Engh, Vivek Mohan, Jarrod P Nagowski, et al.OTO Open|June 8, 2026
Acoustic Vibrational Therapy for the Treatment of Pediatric RhinitisAshoke R Khanwalkar, Alan Greene, Yifei Ma, et al.The Spine Journal : Official Journal of the North American Spine Society|April 7, 2012
Case report: incisional hernia as a complication of extreme lateral interbody fusionTimothy V Galan, Vivek Mohan, Eric O Klineberg, et al.The Journal of Arthroplasty|January 23, 2026
Risk of Revision for Periprosthetic Fracture Following Cementless Total Hip Arthroplasty Using a Specific Type 1 Blade Design Stem: A Registry-Based Cohort StudyDhiren S Sheth, Richard N Chang, Heather A Prentice, et al.The Journal of Bone and Joint Surgery. American Volume|October 7, 2004
Advancement and separation of apex hole eliminators with cementless Duraloc 100 cups. A report of nineteen casesTim A Walde, Alexandra M Claus, Vivek Mohan, et al.Nanoscale|March 23, 2026
An ultrafast self-powered semi-transparent pyro-phototronic device array based on room-temperature amorphous In2S3/NiO heterostructuresMalkeshkumar Patel, Shubham Umeshkumar Gupta, Vivek Mohan More, et al.Plos One|March 2, 2013
Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cellsRebeka Sultana, Tarek Abdel-Fatah, Christina Perry, et al.Pageof 4